Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
International Journal of Obesity (2005)|November 6, 2024
The evolution of the understanding of obesity over the last 100 yearsJavier Gómez-Ambrosi, Victoria Catalán, Gema Frühbeck
Trends in Pharmacological Sciences|June 13, 2006
Aquaporin-7 and glycerol permeability as novel obesity drug-target pathwaysGema Frühbeck, Victoria Catalán, Javier Gómez-Ambrosi, et al.
Frontiers in Physiology|October 10, 2013
Adipose tissue immunity and cancerVictoria Catalán, Javier Gómez-Ambrosi, Amaia Rodríguez, et al.
Current Pharmaceutical Design|July 14, 2007
Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome?Amaia Rodríguez, Victoria Catalán, Javier Gómez-Ambrosi, et al.
Cell Cycle (Georgetown, Tex.)|April 20, 2011
Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance controlAmaia Rodríguez, Victoria Catalán, Javier Gómez-Ambrosi, et al.
FEBS Letters|August 22, 2006
Role of aquaporin-7 in the pathophysiological control of fat accumulation in miceAmaia Rodríguez, Victoria Catalán, Javier Gómez-Ambrosi, et al.
Reviews in Endocrine & Metabolic Disorders|March 17, 2023
Relevance of body composition in phenotyping the obesitiesLaura Salmón-Gómez, Victoria Catalán, Gema Frühbeck, et al.
Expert Opinion on Pharmacotherapy|February 25, 2009
Adipokines in the treatment of diabetes mellitus and obesityVictoria Catalán, Javier Gómez-Ambrosi, Amaia Rodríguez, et al.
Pageof 14